Cogent Biosciences (COGT) Capital Expenditures (2017 - 2026)
Cogent Biosciences (COGT) recorded quarterly Capital Expenditures of $449000.0 in Q1 2026, down 44.64% quarter-over-quarter from $811000.0 in Q4 2025, and down 17.92% on a YoY basis from $547000.0 in Q1 2025.
Cogent Biosciences (COGT) Capital Expenditures (2017 - 2026) Analysis & Trends
Cogent Biosciences' Capital Expenditures history runs 9 years deep, the most recent figure standing at $449000.0 for Q1 2026.
- In Q1 2026, Capital Expenditures fell 17.92% year-over-year to $449000.0; the TTM figure through Mar 2026 stood at $1.5 million (up 38.67% YoY), while the FY2025 annual figure was $1.6 million, up 171.2% from the prior year.
- Capital Expenditures was $449000.0 for Q1 2026 at Cogent Biosciences, down from $811000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $3.3 million in Q3 2022 to a low of $65000.0 in Q3 2025.
- Historically, Capital Expenditures has averaged $719705.9 across 5 years, with a median of $441000.0 in 2022.
- The sharpest annual moves came in 2023 and 2025: Capital Expenditures tumbled 96.35% in 2023, then soared 981.33% in 2025.
- A 5-year view of Capital Expenditures shows it stood at $2.0 million in 2022, then sank by 83.99% to $315000.0 in 2023, then plunged by 76.19% to $75000.0 in 2024, then jumped by 981.33% to $811000.0 in 2025, then tumbled by 44.64% to $449000.0 in 2026.
- The last three Capital Expenditures figures came in at $449000.0 (Q1 2026), $811000.0 (Q4 2025), and $65000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 133.40 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -63,220.27 |
| 10 | Cogent Biosciences | 5.09 Bn | 4.22 Bn | - | 449,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 449,000.00 |
| Mar 31, 2026 | 449,000.00 |
| Dec 31, 2025 | 811,000.00 |
| Dec 31, 2025 | 811,000.00 |
| Sep 30, 2025 | 65,000.00 |
| Sep 30, 2025 | 65,000.00 |
| Jun 30, 2025 | 131,000.00 |
| Jun 30, 2025 | 131,000.00 |
| Mar 31, 2025 | 547,000.00 |
| Mar 31, 2025 | 547,000.00 |
| Dec 31, 2024 | 75,000.00 |
| Dec 31, 2024 | 75,000.00 |
| Sep 30, 2024 | 280,000.00 |
| Sep 30, 2024 | 280,000.00 |
| Jun 30, 2024 | 148,000.00 |
| Jun 30, 2024 | 148,000.00 |
| Mar 31, 2024 | 70,000.00 |
| Mar 31, 2024 | 70,000.00 |
| Dec 31, 2023 | 315,000.00 |
| Dec 31, 2023 | 315,000.00 |